Scarica l'app Stockscreener
13.60
1.23%
-0.17
Dopo l'orario di chiusura:
13.62
0.02
+0.15%
Precedente Chiudi:
$13.77
Aprire:
$13.6608
Volume 24 ore:
81,539
Relative Volume:
0.96
Capitalizzazione di mercato:
$175.58M
Reddito:
$14.48M
Utile/perdita netta:
$-26.11M
Rapporto P/E:
-6.0201
EPS:
-2.2591
Flusso di cassa netto:
$-23.86M
1 W Prestazione:
-1.66%
1M Prestazione:
+7.77%
6M Prestazione:
-16.05%
1 anno Prestazione:
-22.24%
Intervallo 1D:
$13.47
$13.77
Intervallo di 1 settimana:
$13.47
$14.04
Portata 52W:
$12.52
$20.03
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, MRNA, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
13.60 | 178.68M | 14.48M | -26.11M | -23.86M | -2.2591 |
VRTX
Vertex Pharmaceuticals Inc
|
506.74 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
734.81 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
188.94 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
936.00 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.89 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-02 | Iniziato | Alliance Global Partners | Buy |
| 2025-02-28 | Iniziato | Craig Hallum | Buy |
| 2024-07-16 | Reiterato | Maxim Group | Buy |
| 2022-12-22 | Iniziato | Maxim Group | Buy |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2020-09-23 | Iniziato | BTIG Research | Buy |
| 2016-11-28 | Iniziato | Aegis Capital | Buy |
| 2016-08-17 | Iniziato | Wells Fargo | Outperform |
| 2014-04-16 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Mediwound Ltd Borsa (MDWD) Ultime notizie
TD Cowen reiterates MediWound stock rating ahead of trial data By Investing.com - Investing.com Canada
TD Cowen reiterates MediWound stock rating ahead of trial data - Investing.com
MediWound Ltd. (MDWD) Stock Price, News, Quote & History - Yahoo! Finance Canada
MediWound Ltd. Receives Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid - marketscreener.com
MDWD Looks 11.4% Overvalued on GF Value™ - GuruFocus
Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD) - TipRanks
Understanding the Setup: (MDWD) and Scalable Risk - Stock Traders Daily
MediWound receives $3.3M from DoD for NexoBrid development - Investing.com
MediWound receives $3.3M from DoD for NexoBrid development By Investing.com - Investing.com Nigeria
A $21.8M program is developing burn care that can stay at room temperature - Stock Titan
Why The Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD) - menafn.com
TD Cowen Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Reviewers found no safety concerns in MediWound's wound trial. - Stock Titan
MediWound at H.C. Wainwright: value trial looms as catalyst - Investing.com
(MDWD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Director of MediWound (NASDAQ: MDWD) trades shares via spouse - Stock Titan
An FDA-approved burn treatment company’s CEO will join a New York fireside chat. - Stock Titan
Precision Trading with Mediwound Ltd. (MDWD) Risk Zones - Stock Traders Daily
MediWound Ltd.ADR Peer Comparison – Compare with Others - Value Research
Hungarian fund owns double-digit MediWound (MDWD) stake - Stock Titan
MediWound (NASDAQ: MDWD) seller Hess plans $50K, 3,958-share sale - Stock Titan
New Research Estimates a $4 Billion Market by 2028, and MediWound Thinks It May Have a Solution (Nasdaq - Benzinga
MediWound (MDWD) Q2 2026 Earnings Call Transcript - AOL.ca
MediWound (MDWD) Q2 2026 Results: The Available Earnings Metric Delivers a Beat in the Current Update; Closing Reaction: The Stock Records a 1.87% Increase in the Current UpdateRevenue Per Share - vinanet.vn
MediWound (MDWD) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Share-Price Check: Shares Move 1.87% Up on the DayNegative Surprise Momentum - dars.gov.et
What is HC Wainwright's Forecast for MediWound Q3 Earnings? - MarketBeat
Weekly Recap: Reaffirmed 2026 guidance and EscharEx Phase III enrollment - TradingView
MDWD Looks 30.8% Overvalued on GF Value™ - GuruFocus
Mediwound Ltd (MDWD) Stock News Today - TradingKey
MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - Moomoo
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30 - Moomoo
MediWound (MDWD) Stock Faces Cash Burn As Revenue Slips - simplywall.st
Wall Street Zen Downgrades MediWound (NASDAQ:MDWD) to Strong Sell - MarketBeat
MediWound Q2 2026 Earnings Call: Complete Transcript - Sahm
A Quick Look at Today's Ratings for MediWound(MDWD.US), With a Forecast Between $22 to $36 - Moomoo
MDWD Maintains by Oppenheimer -- Price Target Lowered to $30.00 - GuruFocus
T. Rowe Price Associates (MDWD) discloses 5.0% ownership in Mediwound common stock - Stock Titan
MediWound Ltd. Q2 2026 Earnings Call Summary - Yahoo Finance
H.C. Wainwright Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $36 - Moomoo
MediWound (MDWD) Earnings Call zu Q2 2026: VALU auf Kurs, Prognose bekräftigt - TradingKey
Key facts: MediWound Ltd. (MDWD) Q2 $3.09M rev; EscharEx $4B target - TradingView
Oppenheimer Adjusts Price Target on MediWound to $30 From $32, Keeps Outperform Rating - Yahoo Finance
Q2 2026 Mediwound Ltd Earnings Call Transcript - GuruFocus
Mediwound earnings missed by $0.03, revenue topped estimates - Investing.com Canada
MediWound (NASDAQ:MDWD) Issues Earnings Results - MarketBeat
MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record - GuruFocus
MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record NexoBrid Sales and EscharEx ... - ca.finance.yahoo.com
A. G. P. Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $22 - Moomoo
MediWound Q2 2026 Earnings Call Transcript - MarketBeat
MediWound Q2 Earnings Call Highlights - MarketBeat
Mediwound Ltd Azioni (MDWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mediwound Ltd Azioni (MDWD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Rubinstein Samuel | Director |
Sep 01 '26 |
Sale |
12.72 |
525 |
6,678 |
0 |
| Hess Shmuel | COO & Chief Commercial Officer |
Aug 27 '26 |
Sale |
12.92 |
3,958 |
51,149 |
0 |
| Hess Shmuel | COO & Chief Commercial Officer |
Aug 26 '26 |
Sale |
13.00 |
1,865 |
24,245 |
0 |
1.48%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):